Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule ...
Zacks.com on MSN5d
Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last?
Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the ...
ETF Daily News1d
Q1 Earnings Estimate for ENTA Issued By HC Wainwright
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 ...
Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $18.00 Price Target at HC Wainwright
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price objective reduced by HC Wainwright from $27.00 to $18.00 in ...
Enanta Pharmaceuticals to Appeal Ruling in Patent Infringement Case Against Pfizer
Enanta Pharmaceuticals plans to appeal a court decision that Pfizer's Covid-19 antiviral drug, Paxlovid, doesn't infringe on its own patents. The U.S. District Court of Massachusetts ruled that Pfizer ...
Promising Virology Outcomes Boost Buy Rating for Enanta Pharmaceuticals Despite Symptom Assessment Concerns
H.C. Wainwright analyst Ed Arce has maintained their bullish stance on ENTA stock, giving a Buy rating on December 13.Don't Miss Our Christmas ...
Business Wire4d
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...
Enanta to appeal ruling related to ‘953 patent infringement lawsuit
Enanta Pharmaceuticals (ENTA) announced that the United States District Court of Massachusetts has issued a ruling on a summary judgment motion ...